The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...
For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who ...
The move towards a higher threshold for showing efficacy for new CAR-Ts comes after the FDA loosened the requirements for ...
Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...
News-Medical.Net on MSN
New trial shows major survival gains with epcoritamab added to standard R2 therapy
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback